PDIA3 correlates with clinical malignant features and immune signature in human gliomas
Figure 7.Correlation between PDIA3 and immune checkpoint members. PDIA3 is relevant to other immune checkpoint molecules in pan-gliomas (A, B), LGG (C, D), and GBM (E, F) from TCGA (upper row) and CGGA (lower row) datasets.